| Literature DB >> 31480762 |
Alina Pyka-Pająk1, Wioletta Parys2, Małgorzata Dołowy3.
Abstract
The aim of this study was to assess the lipophilicity of selected antiparasitic, antihypertensive and non-steroidal anti-inflammatory drugs (NSAIDs) by means of reversed phase-thin layer chromatography (RP-TLC) as well by using Soczewiński-Wachtmeister's and J. Ościk's equations. The lipophilicity parameters of all examined compounds obtained under various chromatographic systems (i.e., methanol-water and acetone-water, respectively) and those determined on the basis of Soczewiński-Wachtmeister's and Ościk's equations (i.e., RMWS and RMWO) were compared with the theoretical ones (e.g., AlogPs, AClogP, milogP, AlogP, MlogP, XlogP2, XlogP3) and the experimental value of the partition coefficient (logPexp). It was found that the RMWS parameter may be a good alternative tool in describing the lipophilic nature of biologically active compounds with a high and low lipophilicity (i.e., antihypertensive and antiparasitic drugs). Meanwhile, the RMWO was more suitable for compounds with a medium lipophilicity (i.e., non-steroidal anti-inflammatory drugs). The chromatographic parameter 0(a) can be helpful for the prediction of partition coefficients, i.e., AClogP, XlogP3, as well as logPexp of examined compounds.Entities:
Keywords: Ościk’s equation; Soczewiński–Wachtmeister’s equation; anti-inflammatory drugs; antihypertensive drugs; antiparasitic drugs; lipophilicity
Mesh:
Substances:
Year: 2019 PMID: 31480762 PMCID: PMC6749294 DOI: 10.3390/molecules24173187
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Summary of the lipophilicity study of antiparasitic drugs by using the theoretical and RP-TLC methods.
| Lipophilicity Parameters | Antiparasitic Drugs: | |||
|---|---|---|---|---|
| Metronidazole | Ornidazole | Secnidazole | Tinidazole | |
| AlogPs | 0.37 | 0.25 | −0.41 | |
| AC logP | −0.19 | 0.39 | 0.21 | −0.20 |
| milogP | −0.47 | 0.12 | -0.10 | −0.06 |
| AlogP | −0.34 | 0.36 | 0.04 | 0.15 |
| MlogP | 0.44 | 1.13 | 0.80 | 1.00 |
| XlogP2 | −0.14 | 0.66 | 0.32 | 0.74 |
| XlogP3 | −0.02 | 0.60 | 0.22 | −0.36 |
| RMWS(a) a | 0.65 | 1.22 | 0.95 | 0.89 |
| RMWS(m) b | 0.91 | 1.46 | 1.26 | 1.17 |
| RMWO(a) c | 0.94 | 1.42 | 1.21 | 1.11 |
| RMWO(m) d | 1.21 | 1.92 | 1.72 | 1.69 |
| φ0(m) e | 0.564 | 0.676 | 0.656 | 0.612 |
| φ0(a) f | 0.398 | 0.565 | 0.503 | 0.463 |
Where: a RMWS(a)—chromatographic lipophilicity parameter obtained experimentally on the basis of Soczewiński-Wachtmeister’s equation using acetone-water as the mobile phase on silica gel RP-18F254; b RMWS(m)—chromatographic lipophilicity parameter obtained experimentally on the basis of Soczewiński-Wachtmeister’s equation using methanol-water as the mobile phase on silica gel RP-18F254; c RMWO(a)—chromatographic parameter of lipophilicity obtained experimentally on the basis of Ościk’s equation using acetone-water as the mobile phase on silica gel RP-18F254; d RMWO(m)—chromatographic parameter of lipophilicity obtained experimentally on the basis of Ościk’s equation using methanol-water as the mobile phase on silica gel RP-18F254; e φ0(a)—chromatographic lipophilicity parameter calculated on the basis of the parameters of Soczewiński-Wachtmeister’s equation, i.e., RMWS(a) and S, respectively using Equation (6); f φ0(m)—chromatographic lipophilicity parameter calculated on the basis of the parameters of Soczewiński-Wachtmeister’s equation, i.e., RMWS(m) and S, respectively using Equation (6).
Summary of the lipophilicity study of antihypertensive drugs by using the theoretical and RP-TLC methods.
| Lipophilicity Parameters | Antihypertensive Drugs: | |||
|---|---|---|---|---|
| Nilvadipine | Felodipine | Isradipine | Lacidipine | |
| AlogPs | 2.97 | 4.36 | 3.00 | 5.18 |
| AC logP | 2.63 | 4.03 | 3.47 | 4.33 |
| milogP | 3.72 | 4.80 | 3.81 | 5.46 |
| AlogP | 2.09 | 3.55 | 2.17 | 3.82 |
| MlogP | 1.72 | 3.22 | 1.72 | 3.09 |
| XlogP2 | 2.76 | 4.15 | 4.12 | 4.83 |
| XlogP3 | 2.87 | 3.86 | 4.28 | 4.55 |
| RMWS(a) a | 4.07 | 3.75 | 3.54 | 4.51 |
| RMWS(m) b | 3.66 | 4.27 | 3.13 | 5.01 |
| RMWO(a) c | 6.28 | 5.57 | 5.67 | 6.63 |
| RMWO(m) d | 5.57 | 6.57 | 5.08 | 6.89 |
| φ0(m) e | 0.886 | 0.929 | 0.837 | 0.937 |
| φ0(a) f | 0.764 | 0.775 | 0.751 | 0.793 |
Summary of the lipophilicity study of NSAIDs by using the theoretical and RP-TLC methods.
| Lipophilicity Parameters | Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): | ||||||
|---|---|---|---|---|---|---|---|
| Mefenamic Acid | Indomethacin | Nabumetone | Phenylbutazone | Carprofen | Ketoprofen | Flurbiprofen | |
| AlogPs | 4.58 | 4.25 | 3.41 | 2.81 | 4.09 | 3.29 | 3.57 |
| AC logP | 4.01 | 3.83 | 3.56 | 3.29 | 3.79 | 2.99 | 3.46 |
| milogP | 4.77 | 3.99 | 3.40 | 4.56 | 4.32 | 3.59 | 4.05 |
| AlogP | 3.96 | 4.21 | 2.80 | 3.95 | 4.09 | 3.34 | 3.66 |
| MlogP | 3.47 | 3.32 | 3.04 | 3.70 | 3.18 | 3.37 | 3.89 |
| XlogP2 | 4.16 | 4.18 | 3.06 | 3.71 | 3.79 | 3.22 | 3.76 |
| XlogP3 | 5.12 | 4.27 | 3.08 | 3.16 | 4.05 | 3.12 | 4.16 |
| RMWS(a) a | 2.61 | 2.57 | 3.08 | 1.72 | 2.56 | 1.26 | 1.87 |
| RMWS(m) b | 2.49 | 2.19 | 3.12 | 1.84 | 2.34 | 1.47 | 1.98 |
| RMWO(a) c | - | - | - | - | - | - | - |
| RMWO(m) d | 3.74 | 4.08 | 2.52 | 3.54 | 2.77 | 3.76 | 2.26 |
| φ0(m) e | 0.865 | 0.790 | 0.903 | 0.686 | 0.820 | 0.687 | 0.771 |
| φ0(a) f | 0.789 | 0.747 | 0.787 | 0.715 | 0.754 | 0.640 | 0.930 |
The experimental partition coefficients (logPexp) of the examined compounds.
| Drug | logPexp |
|
|---|---|---|
|
| ||
| Metronidazole | –0.22 [ | |
| –0.02 [ | 0.10 (± 0.44) | |
| 0.75 [ | ||
| Ornidazole | 0.23 [ | |
| 0.59 [ | 0.41 (± 0.25) | |
| Secnidazole | 0.22 [ | |
| Tinidazole | –0.35 [ | |
| 0.70 [ | 0.18 (± 0.74) | |
|
| ||
| Nilvadipine | - | |
| Felodipine | 3.86 [ | |
| 4.46 [ | 4.16 (± 0.42) | |
| Isradipine | 4.28 [ | |
| Lacidipine | - | |
|
| ||
| Mefenamic acid | 5.12 [ | |
| Indomethacin | 4.10 [ | |
| 4.27 [ | 4.18 (± 0.12) | |
| Nabumetone | 3.08 [ | |
| Phenylbutazone | 3.16 [ | |
| Carprofen | - | |
| Ketoprofen | 3.12 [ | |
| 3.14 [ | 3.13 (± 0.01) | |
| Flurbiprofen | 3.84 [ | |
| 4.16 [ | 4.00 (± 0.23) |
Figure 1Similarity analysis for antiparasitic drugs, including: (a) comparison of the chromatographic and theoretical parameters of lipophilicity. (b) comparison of the chromatographic, theoretical and experimental parameters of lipophilicity.
Figure 2A similarity analysis for antihypertensive drugs, including: (a) comparison of the chromatographic and theoretical parameters of lipophilicity. (b) comparison of the chromatographic, theoretical and experimental parameters of lipophilicity.
Figure 3Similarity analysis for the examined NSAIDs, including: (a) comparison of the chromatographic and theoretical parameters of lipophilicity; (b) comparison of the chromatographic, theoretical and experimental parameters of lipophilicity